10/23/13 - Agencia Nacional de Información (Havana) - Cuba Presents at Latin American Congress Natural Products to Treat Cancer
HAVANA, Cuba, Oct 23 (acn) The development of natural products applied to
humans in Cuba was among topics debated on Wednesday at the 20th Latin
American Congress on Pharmacology and Therapeutics (Latinfarma 2013), under
way in Havana with the participation of 800 delegates from about 40
Presented at the meeting, at the capitals Convention Center, were the
results of peptide RJLB-14 in the treatment of patients with epithelial
Dr. Alexis Díaz-García and other scientists from the business group of
biopharmaceutical labs (LABIOFAM) presented the potential of this compound
to treat metastatic breast cancer, the preclinical assessment of which
determined its high spectrum of effectiveness, the dose-response
relationship, and its influence in the reduction of tumors.
For its part, State Center for Controlling Drugs and Medical Equipment
focused on the economic implications of the consumption and safety of
drugs, while foreign experts will debate on cancer vaccines and natural
products for the treatment of anti-inflammatory ailments.
For the fist time, Cuba is the venue of the Latin American Congress on
Pharmacology and Therapeutics, which is held parallel to the 5th
Iberian-American Congress on Pharmacology, and the 11th National Congress
and the 5th International Congress on the specialty.
CUBA-L FAIR USE NOTICE
This server contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of Cuba's political, economic, human rights, international, cultural, educational, scientific, sports and historical issues, among others. We distribute the materials on the basis of a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107. The material is distributed without profit. The material should be used for information, research and educational purposes. For more information go to: http://www.law.cornell.edu/ uscode/17/107.shtml.